Back to news

February 25, 2019 | International, Other Defence

A New Layer of Medical Preparedness to Combat Emerging Infectious Disease

DARPA has selected five teams of researchers to support PREventing EMerging Pathogenic Threats (PREEMPT), a 3.5-year program first announced in January 2018 to reinforce traditional medical preparedness by containing viral infectious diseases in animal reservoirs and insect vectors before they can threaten humans. Through studies in secure laboratories and simulated natural environments, the PREEMPT researchers will model how viruses might evolve within animal populations, and assess the safety and efficacy of potential interventions. Autonomous Therapeutics, Inc., Institut Pasteur, Montana State University, The Pirbright Institute, and the University of California, Davis, lead the PREEMPT teams.

“DARPA challenges the PREEMPT research community to look far left on the emerging threat timeline and identify opportunities to contain viruses before they ever endanger humans,” said Dr. Brad Ringeisen, the DARPA program manager for PREEMPT. “One of the chief limitations of how infectious disease modeling is currently conducted is that it forecasts the trajectory of an outbreak only after it is underway in people. The best that data can do is inform a public health response, which places the United States in a reactive mode. We require proactive options to keep our troops and the homeland safe from emerging infectious disease threats.”

According to the World Health Organization (WHO), approximately 60 percent of emerging infectious diseases reported globally are zoonoses, meaning that they were initially diseases of animals and at some point became capable of infecting people. Zoonotic diseases are responsible for millions of human deaths every year, and the scope of the challenge is increasing due to the densification of livestock production, human encroachment into natural spaces, and upward trends in globalization, temperature, and population.

Ebola is a high-profile example of a zoonotic disease. Despite being relatively difficult to spread — requiring direct contact with fluids from infected organisms — a string of outbreaks over the past five years has highlighted the threat it could present once established in densely populated areas. Researchers express even greater concern over the pandemic potential of new strains of the influenza virus and other airborne pathogens. Even in the United States and its territories, where viruses do not frequently emerge directly from animal reservoirs, vector-borne transmission of zoonoses such as West Nile virus disease is on the rise.

The 2018 U.S. National Biodefense Strategy directs that it is essential to detect and contain such bio-threats, adopting a proactive posture to improve preparedness while also assessing and managing any biosecurity risks related to possible interventions. “The health of the American people depends on our ability to stem infectious disease outbreaks at their source, wherever and however they occur,” the document states. For the Department of Defense, that obligation extends to protection of deployed service members, who often operate in countries that are “hot spots” for emerging viruses yet lack robust public health infrastructure.

The teams DARPA selected for PREEMPT comprise multidisciplinary researchers who bring expertise and field experience from around the world, some of whom represent institutions from nations at high risk from emerging infectious disease. Institutions participating as sub-contractors to DARPA receive funding from the lead organizations except as otherwise noted.

The PREEMPT teams proposed to model specific diseases to assess the risk of spillover from animals into humans, identify key bottlenecks in the process as opportunities for intervention, and develop and assess novel, animal- or insect-focused interventions with built-in safety switches to prevent cross-species jump. The teams will collect samples from animal reservoirs in the field for analysis in secure, bio-contained facilities; some teams will also conduct analysis on existing banked samples and datasets. DARPA is not funding the release of PREEMPT interventions into the environment.

  • Autonomous Therapeutics, Inc., under principal investigator Dr. Ariel Weinberger, leads a team made up of CSIRO Australian Animal Health Laboratory; Navy Medical Research Unit-2, funded directly by DARPA; University of California, Los Angeles; University of Chicago Medical School; and University of Texas Medical Branch. The team will study air-borne highly pathogenic avian influenza virus in birds and small mammals, and tick-borne Crimean-Congo hemorrhagic fever virus.
  • The Center for Comparative Medicine and the One Health Institute at the University of California, Davis, under principal investigator Dr. Peter Barry and co-PI Dr. Brian Bird, respectively, lead a team made up of the Leibniz Institute for Experimental Virology; Mount Sinai School of Medicine; Rocky Mountain Laboratories of the National Institutes of Health (NIH), to be funded directly by DARPA; The Vaccine Group, Ltd., a spin-out of University of Plymouth; University of Glasgow; University of Idaho; and University of Western Australia. The team will examine Lassa virus spillover from rodents, and study Ebola virus in rhesus macaques.
  • The Institut Pasteur, under principal investigator Dr. Carla Saleh, leads a team made up of Institut Pasteur International Network partners in Cambodia, Central African Republic, France, French Guiana, Madagascar, and Uruguay; Latham BioPharm Group; and Virginia Polytechnic Institute and State University. The team will study several mosquito-borne arboviruses, which refers broadly to animal or human viruses transmitted by insects, as well as mosquito-specific viruses that could interfere with arbovirus infection in the insect vector.
  • Montana State University, under principal investigator Dr. Raina Plowright, leads a team made up of the Cary Institute of Ecosystem Studies; Colorado State University; Cornell University; Griffith University; Johns Hopkins University; NIH's Rocky Mountain Laboratories, funded directly by DARPA; Pennsylvania State University; Texas Tech University; University of California, Berkeley; University of California, Los Angeles; and University of Cambridge. The team will study henipavirus spillover from bats. The henipavirus genus of viruses contains multiple biothreat agents as categorized by NIH and the Centers for Disease Control and Prevention (CDC).
  • The Pirbright Institute, under principal investigator Dr. Luke Alphey, leads a team made up of the University of Nottingham and the University of Tartu. The team seeks to disrupt mosquito transmission of flaviviruses, which include Dengue fever, West Nile, and Zika viruses.

Modeling and quantification are as important as new experimental technologies in preventing cross-species jumps. The results from modeling will inform when, where, and at what levels such interventions could be applied to achieve the greatest health benefits. Interventions under consideration include animal- or insect-targeted vaccines, therapeutic interfering particles, gene editors, and indirect approaches informed by environmental and ecological factors that affect how viruses are spread — for instance, understanding the environmental stressors that drive bats into closer contact with humans and devising mitigating options to reduce the likelihood of that contact.

The research teams' approaches each come with a unique set of potential benefits and challenges, and the teams are responsible for assessing and demonstrating to DARPA the safety, efficacy, stability, and controllability of their proposed interventions. In the future, these considerations could factor into decisions by the ultimate end users — communities, governments, and regulators — on which strategies to pursue to prevent new zoonoses.

DARPA and the PREEMPT teams receive guidance from independent expert advisors in the ethical, legal, social, and regulatory aspects of the life sciences. These individuals include Dr. Claudia Emerson, director of the Institute on Ethics & Policy for Innovation at McMaster University; Dr. Matt Kasper, legislative liaison for the U.S. Navy's Bureau of Medicine and Surgery, and a former deputy director of field laboratory operations at the Naval Medical Research Center; and Dr. Steve Monroe, associate director for Laboratory Science and Safety at the CDC, and a former deputy director of the CDC's National Center for Emerging and Zoonotic Infectious Diseases.

The teams also benefit from established relationships with local universities, communities, and governments based on prior or ongoing research. These relationships will facilitate initial field collection and help to familiarize stakeholders with PREEMPT technologies as they are being developed. DARPA is also beginning outreach to the WHO as a potential avenue for future transition of PREEMPT technologies.

DARPA intends that PREEMPT teams will perform fundamental research and publish results for review by the broader scientific community.

https://www.darpa.mil/news-events/2019-02-19

On the same subject

  • Leonardo eyes enhanced firefighting configuration for its C-27J aircraft

    March 26, 2019 | International, Aerospace

    Leonardo eyes enhanced firefighting configuration for its C-27J aircraft

    The 16th Aerial Firefighting Europe event is returning to Nimes, France, March 19 to 20 with a new entry, Leonardo's C-27J aircraft in firefighting configuration. The C-27J firefighter with roll-on/roll-off Fire Attack System (FAS) made by Simplex Aerospace–a leader of advanced aerial application systems–represents an effective solution in airborne firefighting technology and capability. This enhanced firefighter configuration is a flexible solution, ideal for enhancing the capabilities of the C-27J multi-mission aircraft with significantly lower acquisition and operating costs than a dedicated firefighting platform. The Simplex Fire Attack System can be easily installed or removed by a small team in approximately 60 to 90 minutes via the aircraft's rear loading ramp. No major structural modifications are required to the airframe. The main tank has a maximum capacity of 10,600 l (2,800 US gallons); 568 litres (150 US gallons) of foam retardant can also be added. The firefighting system is one of the options that C-27J customers can add to the C-27J Spartan new baseline configuration, which incorporates a brand new avionics system designed to comply with Next Generation Air Traffic Control requirements, new cockpit control panels and LED aircraft lights. Operators will enjoy improved operational cost and performance within the aircraft flyaway price. The firefighting capability and the new baseline configuration are also being offered as a retrofit to current operators that want to upgrade their C-27J fleet. While offering the C-27J firefighter with the Simplex Aerospace roll-on/roll-off Fire Attack System, Leonardo, in collaboration with the European SCODEV Consortium, is also studying and testing a further innovative solution to enhance the C-27J's firefighting potential. The SCODEV scooping device will provide increased operational flexibility by allowing the water tank to be filled from a stretch of water, without the need to return to base. The system will provide a scooping device for the safe loading of water (sea, lakes, rivers) from around 30 metres above the surface, with a roll-on / roll-off approach to allow the aircraft different roles between firefighting, emergency support (medevac) and transport. Eighty-five C-27J Spartans have already been ordered by the air forces of Italy, Greece, Bulgaria, Lithuania, Romania, Slovakia, United States, Mexico, Australia, Peru, Kenya, Morocco, Chad and Zambia. https://www.skiesmag.com/press-releases/leonardo-eyes-enhanced-firefighting-configuration-for-its-c-27j-aircraft

  • U.S. General Says Future UK Fighter Jet Must Be Compatible With F-35

    July 26, 2018 | International, Aerospace

    U.S. General Says Future UK Fighter Jet Must Be Compatible With F-35

    BERLIN (REUTERS) - THE top U.S. Air Force general in Europe on Wednesday said it was critical to ensure any future British fighter jet was compatible with the U.S. F-35 stealth fighter built by Lockheed Martin for a number of U.S. allies, including Britain. General Tod Wolters, commander of U.S. and NATO air forces in Europe, told reporters on a teleconference that he had watched Britain's unveiling of a new fighter jet development effort electronically from afar, but had not spoken with UK officials specifically about the new combat aircraft program. UK officials launched the new Tempest fighter jet program last week at the Farnborough Airshow outside London. Wolters said officials from both countries had discussed future combat air capabilities in the past, and agreed on the need to ensure any new systems could work with existing weapons. "One of the key ingredients that has to go into any future systems is to make sure that it's interoperable with existing systems and certainly the systems that that UK is embracing," he said, referring to Britain's growing fleet of F-35 fighter jets. "As the UK decides to go forward with a system that could be called Tempest, we would hope that it would be as interoperable as possible with the great system that they've just acquired ... the F-35B," he said. CERTAIN He said he was certain that Britain was looking very closely at the issue, which he called "critical". Britain has said it is looking for international partners for the new development program, and is already in discussions with Sweden, Japan and other countries. Wolters sidestepped a question on whether the United States could also play a role. He did announce plans to bring U.S. radar-evading, or fifth-generation, aircraft to Europe in the coming months to continue efforts to integrate those capabilities with fifth-generation aircraft operated by allies, and with older fourth-generation weapons in Europe. He declined to provide details on whether the F-35 or F-22, both radar-evading aircraft, would be brought to Europe, or when. https://www.usnews.com/news/world/articles/2018-07-25/us-general-says-future-uk-fighter-jet-must-be-compatible-with-f-35

  • Anduril Industries Awarded Air Defense Production Contract with Department of Defense

    October 9, 2024 | International, Aerospace

    Anduril Industries Awarded Air Defense Production Contract with Department of Defense

    This contract will deliver more than 500 Roadrunner-Ms and additional Pulsar electronic warfare capabilities, addressing the growing threat of unmanned aerial systems (UAS) attacks against U.S. forces

All news